JP2005516901A - １Ｈ−ピロロ［３，２−ｂ］ピリジン−３−カルボン酸アミド化合物 - Google Patents

１Ｈ−ピロロ［３，２−ｂ］ピリジン−３−カルボン酸アミド化合物 Download PDF

Info

Publication number
JP2005516901A
JP2005516901A JP2003545655A JP2003545655A JP2005516901A JP 2005516901 A JP2005516901 A JP 2005516901A JP 2003545655 A JP2003545655 A JP 2003545655A JP 2003545655 A JP2003545655 A JP 2003545655A JP 2005516901 A JP2005516901 A JP 2005516901A
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
pyrrolo
pyridine
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003545655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005516901A5 (fr
Inventor
メイナード、ジョージ、ディ．
ゴーシュ、マヌカ
オードネル、クリストファー、ジェイ．
Original Assignee
ニューロジェン コーポレイション
ファイザー プロダクツ、インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニューロジェン コーポレイション, ファイザー プロダクツ、インコーポレイテッド filed Critical ニューロジェン コーポレイション
Publication of JP2005516901A publication Critical patent/JP2005516901A/ja
Publication of JP2005516901A5 publication Critical patent/JP2005516901A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2003545655A 2001-11-19 2002-11-19 １Ｈ−ピロロ［３，２−ｂ］ピリジン−３−カルボン酸アミド化合物 Pending JP2005516901A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33302701P 2001-11-19 2001-11-19
PCT/US2002/037157 WO2003044018A1 (fr) 2001-11-19 2002-11-19 Amides d'acide 1h-pyrrolo[3,2-b]pyridine-3-carboxylique

Publications (2)

Publication Number Publication Date
JP2005516901A true JP2005516901A (ja) 2005-06-09
JP2005516901A5 JP2005516901A5 (fr) 2006-01-19

Family

ID=23300941

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003545655A Pending JP2005516901A (ja) 2001-11-19 2002-11-19 １Ｈ−ピロロ［３，２−ｂ］ピリジン−３−カルボン酸アミド化合物

Country Status (7)

Country Link
EP (1) EP1453831A1 (fr)
JP (1) JP2005516901A (fr)
AU (1) AU2002366092A1 (fr)
BR (1) BR0214301A (fr)
CA (1) CA2467542A1 (fr)
MX (1) MXPA04004711A (fr)
WO (1) WO2003044018A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865208B1 (fr) 2004-01-16 2009-01-16 Sanofi Synthelabo Derives de 1,4-diazabicyclo[3.2.1]octanecarboxmique, leur preparation et leur application en therapeutique
FR2890072A1 (fr) * 2005-09-01 2007-03-02 Fournier S A Sa Lab Nouveaux composesde pyrrolopyridine
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
EP3004057B1 (fr) 2013-06-05 2018-07-25 C&C Research Laboratories Dérivés hétérocycliques et leur utilisation autant qu'inhibiteurs de stat 3
GB201317363D0 (en) 2013-10-01 2013-11-13 Eisai Ltd Novel compounds
CN116102549A (zh) * 2021-11-09 2023-05-12 暨南大学 5-醛基杂环酰胺类化合物及其应用
WO2023082044A1 (fr) * 2021-11-09 2023-05-19 暨南大学 Composé amide hétérocyclique de 5-formyle et son utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750702A (en) * 1993-10-27 1998-05-12 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands

Also Published As

Publication number Publication date
BR0214301A (pt) 2004-10-13
WO2003044018A1 (fr) 2003-05-30
AU2002366092A1 (en) 2003-06-10
CA2467542A1 (fr) 2003-05-30
MXPA04004711A (es) 2005-08-16
EP1453831A1 (fr) 2004-09-08

Similar Documents

Publication Publication Date Title
EP1177177B1 (fr) 4-oxo-quinoline-3-carboxamides substitues: ligands des recepteurs cerebraux gaba
EP1228069B1 (fr) Composes heteroaromatiques bicycliques et tricycliques
US6828329B2 (en) Aryl fused substituted 4-oxy-pyridines
US20040110778A1 (en) Heterocyclic compounds as ligands of the GABAA receptor
WO2002002557A2 (fr) Derives imidazo[1,2-a]pyridine 2-substitues
US6656941B2 (en) Aryl substituted tetrahydroindazoles
US20020035120A1 (en) Oxo-imidazopyridine-carboxamides
JP2002540203A (ja) Ｎｋ−３および／またはｇａｂａ（ａ）受容体リガンドとしての４−置換キノリン誘導体
JP2003508385A (ja) 縮合ピロールカルボキサミド：ｇａｂａ脳受容体リガンド
JP2005525333A (ja) 置換縮合ピラゾールカルボン酸アリールアミド及び関連化合物
JP2005516901A (ja) １Ｈ−ピロロ［３，２−ｂ］ピリジン−３−カルボン酸アミド化合物
US6743817B2 (en) Substituted fused pyrroleimines and pyrazoleimines
US6861529B2 (en) Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
US6673811B1 (en) 1H-pyrrolo [3,2-b] pyridine-3-carboxylic acid amines as GABAA receptor ligands
US20080032975A1 (en) Substituted Fused Pyrroleoximes and Fused Pyrazoleoximes

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051121

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051121

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090708

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090710

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091013

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091023

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091110

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100105